HIPAA Pharmacy Transaction Compliance Date Updates
Summary
This document updates compliance and other dates presented in the final rule that appeared in the December 13, 2024 Federal Register titled "Administrative Simplification: Modifications of Health Insurance Portability and Accountability Act of 1996 (HIPAA) National Council for Prescription Drug Programs (NCPDP) Retail Pharmacy Standards; and Modification of the Medicaid Pharmacy Subrogation Standard" to conform with the subsequent final rule that appeared in the February 11, 2025 Federal Register.
Compliance Requirements
- #1
All covered entities must be in compliance with Version F6 and Version 15 beginning April 14, 2028; State Medicaid agencies must be in compliance with Version 10 beginning April 14, 2028; Beginning August 14, 2027, all covered entities, as agreed to by trading partners, may use either Version D.0 and Version 1.2, or Version F6 and Version 15 for 8 months as a transition period prior to full compliance; Beginning August 14, 2027, state Medicaid agencies, as agreed to by trading partners, may use either Version 3.0 or Version 10 for 8 months as a transition period prior to full compliance
Deadline: 2028-04-14(April 14, 2028)
Market Impacts
Mandatory adoption of updated electronic transaction standards (Version F6 and Version 15 for retail pharmacy transactions, Version 10 for Medicaid pharmacy subrogation) for all covered entities and state Medicaid agencies; 8-month transition period allowing covered entities and state Medicaid agencies to use either old or new standards as agreed with trading partners, providing flexibility during implementation; Mandatory system upgrades and technical changes required to support new transaction standards (Version F6, Version 15, and Version 10)
Validated Company Impacts
Alignment Healthcare, Inc.
Alignment Healthcare operates as a Medicare Advantage plan that contracts directly with CMS, focusing on senior healthcare services rather than pharmacy operations or electronic transaction processing. The rule specifically targets covered entities handling retail pharmacy transactions and Medicaid pharmacy subrogation, which are not core to this company's business model of care coordination and member engagement through their proprietary technology platform. The rule's focus on mandatory electronic transaction standards and regulatory compliance deadlines directly aligns with the company's high-impact 'Regulatory Changes' risk and 'Dependence on Technology Platform' risk, as it requires system upgrades and technical changes that could significantly affect operations and financial performance.
BrightSpring Health Services, Inc.
BrightSpring Health Services operates pharmacy and prescription management services that directly handle retail pharmacy transactions and Medicaid pharmacy services, making them a covered entity subject to HIPAA electronic transaction standards. Their business model involves processing prescription claims and coordinating with payers, which falls squarely under the rule's requirements for adopting updated NCPDP standards and Medicaid pharmacy subrogation protocols. The rule focuses on technical standards compliance for pharmacy transactions and Medicaid subrogation, which does not directly align with the company's disclosed risk factors. While the company has regulatory compliance risks (13 identified), none specifically mention pharmacy transaction standards, electronic health data formats, or Medicaid subrogation requirements that this rule addresses.
Cigna Group
Cigna Healthcare operates as a major health insurance provider, making it a covered entity under HIPAA that must comply with electronic transaction standards for pharmacy claims and Medicaid subrogation. The company's healthcare operations directly align with the rule's requirements for adopting updated NCPDP standards for retail pharmacy transactions and Medicaid pharmacy subrogation processes. The HIPAA/NCPDP pharmacy transaction rule focuses entirely on healthcare compliance and technical system requirements, while the company's disclosed risks are exclusively financial and real estate related (interest rate risk, mortgage valuations, credit quality, office sector weakness). There is zero overlap between the regulatory compliance requirements and the company's identified risk factors.
CENTENE CORP
Centene operates extensively in Medicaid managed care services, making it a covered entity directly subject to HIPAA administrative simplification requirements. The company's pharmacy transactions and Medicaid subrogation activities would require compliance with the updated NCPDP standards and Medicaid pharmacy subrogation modifications. The rule focuses on technical standards for pharmacy transactions and Medicaid subrogation, which does not align with the company's disclosed risk factors. The company's regulatory compliance risks center on Medicare/Medicaid revenue impacts and operational costs, not technical transaction standards or pharmacy-specific requirements.
Elevance Health, Inc.
Elevance Health operates as a major health benefits provider offering managed care and Medicare Advantage plans, which are covered entities under HIPAA regulations. The company's healthcare operations involve electronic pharmacy transactions and Medicaid-related services that would require compliance with the updated NCPDP standards for retail pharmacy transactions and Medicaid pharmacy subrogation. The company has a general regulatory compliance risk factor, but this specific HIPAA/NCPDP pharmacy transaction rule targets specialized healthcare entities (covered entities and state Medicaid agencies) that handle prescription drug transactions, which does not align with the company's disclosed risk profile focused on Medicare Advantage, business efficiency, and acquisition integration. The rule's technical pharmacy transaction standards have no apparent connection to the company's specific operational or financial risks.
HCA Healthcare, Inc.
HCA Healthcare operates hospitals and healthcare facilities that qualify as covered entities under HIPAA, requiring compliance with electronic transaction standards for pharmacy and healthcare operations. The company's extensive healthcare services and pharmacy operations directly align with the rule's requirements for adopting updated NCPDP retail pharmacy standards and electronic transaction processing. The rule focuses on technical compliance with electronic transaction standards for pharmacy operations, which does not align with the company's disclosed risk factors that emphasize financial, staffing, and physician retention challenges. While the company has regulatory compliance risks in its profile, none specifically mention pharmacy transaction standards or electronic health data requirements that this rule addresses.
HUMANA INC
Humana operates as a major health insurance company and covered entity under HIPAA, directly subject to the rule's requirements for electronic transaction standards compliance. The company's core business involves processing pharmacy claims and healthcare transactions that fall under the NCPDP retail pharmacy standards and Medicaid pharmacy subrogation requirements. The rule focuses on technical compliance with pharmacy transaction standards and Medicaid subrogation requirements, which does not align with the company's disclosed risk factors of regulatory investigations, litigation, insurance costs, provider disputes, or reputation damage. The company's risk profile shows no specific pharmacy, healthcare IT, or electronic transaction risks that would be directly affected by these HIPAA/NCPDP technical standard updates.
MOLINA HEALTHCARE, INC.
Molina Healthcare operates as a major Medicaid managed care organization, directly falling under the rule's jurisdiction as a covered entity handling pharmacy transactions and Medicaid subrogation. The company's $30.6B Medicaid segment requires compliance with the updated NCPDP standards for retail pharmacy transactions and Medicaid pharmacy subrogation standards. The rule focuses on administrative transaction standards for pharmacy and Medicaid operations, which does not directly address the company's primary cybersecurity and data breach risks. While any system upgrades could introduce minor technical vulnerabilities, this is an indirect connection rather than a direct alignment with the company's stated technology cybersecurity concerns.
TENET HEALTHCARE CORP
Tenet Healthcare Corp operates as a covered entity under HIPAA regulations, providing healthcare services that involve electronic health transactions and pharmacy services. The company's core business operations directly align with the rule's requirements for adopting updated electronic transaction standards (Version F6 and Version 15) for retail pharmacy transactions and system upgrades. The rule focuses on mandatory technical standards adoption for healthcare transactions and pharmacy operations, which does not directly align with the company's cybersecurity-focused risk profile. While there is minimal overlap in the regulatory compliance risk category, the company's specific cybersecurity threats and incident management concerns are not addressed by this pharmacy transaction standards update.
UNIVERSAL HEALTH SERVICES INC
Universal Health Services operates healthcare facilities that qualify as covered entities under HIPAA, requiring compliance with electronic transaction standards for pharmacy and administrative functions. The company's acute care and behavioral health services involve prescription drug processing and Medicaid billing, directly falling under the rule's requirements for Version F6, Version 15, and Medicaid subrogation standards. The rule focuses on HIPAA administrative simplification and pharmacy transaction standards, which does not align with the company's disclosed risk factors. The company's regulatory risks primarily concern healthcare law changes and compliance costs, but none specifically mention pharmacy transactions, electronic standards, or HIPAA administrative requirements that this rule addresses.
UNITEDHEALTH GROUP INC
UnitedHealth Group operates as both a healthcare insurer (UnitedHealthcare) and a pharmacy services provider (Optum Rx), making it a covered entity under HIPAA that must comply with the updated NCPDP retail pharmacy and Medicaid pharmacy subrogation standards. The company's extensive Medicare Advantage, commercial, and Medicaid insurance operations, along with its pharmacy care services, directly fall under the rule's jurisdiction requiring electronic transaction standard updates. The rule focuses on HIPAA administrative simplification and pharmacy transaction standards, which does not align with the company's disclosed risk factors related to Medicare Advantage funding pressures, revenue challenges, risk adjustment models, medical cost management, and Medicaid redeterminations. The company's regulatory compliance risk mentions funding and benefit reductions but not electronic transaction standards or pharmacy-specific requirements.
Waystar Holding Corp.
Waystar Holding Corp. explicitly operates as a HIPAA covered entity and business associate providing clearinghouse services and revenue cycle management, which directly falls under this rule's jurisdiction requiring compliance with updated electronic transaction standards. The company's core business model involves HIPAA compliance and electronic health transactions, making it directly subject to the mandatory adoption of Version F6 and Version 15 standards for retail pharmacy transactions. The rule focuses on mandatory technical compliance requirements for healthcare data standards and system upgrades, which does not align with any of the company's disclosed financial, operational, or market competition risks. The company's risk profile centers on cash flow, financing, working capital, interest payments, and acquisition integration - none of which relate to regulatory compliance or healthcare IT system changes.